Psychedelics Archives - InvestorWire (IW)

Friday Apr 16, 2021 - 12:16 pm

Largely Untapped Market for Hallucinogenic Draws Attention of Researchers at XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT)

XPhyto Therapeutics Corp., a life sciences technology accelerator, is looking for ways to turn promising psychedelics into therapeutic pharmaceutical drugs, and recently added mescaline to its study profileMescaline is illegal under U.S. federal law, but some state-centric efforts to legalize or decriminalize the hallucinogenic have launched in a manner similar to the populace effort that produced a wave of cannabis product legalizationMescaline has historically defied…

Monday Apr 12, 2021 - 1:02 pm

XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Files First Order for Rapid COVID Test Kits Amid European Regulatory Approval

Bioscience technology accelerator XPhyto Therapeutics Corp. recently announced it had placed its first order for its Covid-ID Lab rapid, portable virus test from its German development partnerXPhyto received approval for the test kit last month from European regulators with oversight of in vitro diagnostic device (CE-IVD) use certification and the internationally agreed-on ISO 13485 medical product quality standardsThe Covid-ID Lab is designed to help beleaguered…

Tuesday Apr 06, 2021 - 1:23 pm

Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) Completes Pre-Clinical Studies, Progresses Two Drug Candidates

Cybin has completed more than 20 pre-clinical studies in record time.Company is advancing two new therapeutic candidates with enhanced, improved properties.Drug candidates are designed to treat serious psychiatric conditions with high unmet medical needs. Cybin (NEO: CYBN) (OTCQB: CLXPF), a leading biotech company focused on progressing psychedelic therapeutics, has completed key research studies both in vitro and in vivo. The company recently announced that it had completed its…

Monday Mar 29, 2021 - 11:53 am

Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) Orders First Functional Mushroom Shipment for Global E-Commerce Portal

PULL expands into EU through initial sale of cannabis oil extracts to German pharmaceutical companySale to Germany expected to pave way for additional supply agreements throughout EuropeCompany orders first shipment of functional mushroom products for direct-to-consumer e-commerce portal, expects $15,000 gross monthly sales for each formulationPULL’s new state-of-the-art facility constructed to EU GMP standards for worldwide exports With a focus on the cannabis, hemp, functional…

Monday Mar 22, 2021 - 11:39 am

Pure Extracts Technologies Corp.’s (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) Subsidiary Pure Mushrooms Corp. Submits Application to Health Canada for a Dealer’s License

Pure Extracts Technologies Corp.’s subsidiary Pure Mushrooms Corp. has submitted an application to Health Canada for a Dealer’s LicenseAward of a Dealer’s License will enable company to procure controlled substances, conduct research, carry out business-to-business salesPure Extracts has recently commenced a study into psilocybin-based active treatments, with research set to be carried out under auspices of Toronto Institute of Pharmaceutical TechnologyFunctional mushroom, psychedelic drug market…

Wednesday Mar 17, 2021 - 3:09 pm

Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) Takes Milestone Step Toward Offering Product Across Canada

PULL subsidiary has submitted application to Health Canada to amend license to permit sales of productThe submission follows recent announcement that Pure Extracts inked distribution agreement with an important Canadian Licensed Producer (“LP”)PULL plans on distributing exclusive vape, edible products to retail buyers across Canada As a result of the its recently inked distribution agreement with an important Canadian LP, Pure Extracts Technologies (CSE: PULL) (OTC:…

Tuesday Mar 09, 2021 - 3:09 pm

Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) Upsizes Its Bought Deal Offering Due to Surge in Demand

Cybin's latest offering generated exceptional demand; announces upsize of "bought deal" offeringBurgeoning psychedelic sector attracts investors’ attention as compound may prove effective in mental health treatments.Cybin appears set for rapid growth as research accelerates, public acceptance grows. Cybin (NEO: CYBN) (OTCQB: CLXPF), a biotech company focused on psychedelic therapeutics for various psychiatric and neurological conditions, has announced that it has upsized the terms of its…

Monday Mar 08, 2021 - 11:08 am

Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) and Canada House Wellness Group (CSE: CHV) Partner, Bringing New Cannabis 2.0 to More Canadians

Canada House subsidiary Abba Medix to distribute Pure Extract line of full spectrum oil vape and edible products throughout its nationwide networkPartnership widens Pure Extracts’ footprint in Canada’s growing Cannabis 2.0 marketGlobal extraction product market expected to reach $28.5 billion in next six yearsNew agreement strengthens Pure Extracts’ sales channels as it looks towards international expansion There’s plenty of media coverage about increasing legalization of…

Thursday Mar 04, 2021 - 12:14 pm

Cybin Inc. (NEO: CYBN) (OTC: CLXPF) Newly Acquired Subsidiary Achieves Earn-Out Milestone —Successful Synthesis of Multiple Tryptamine Derivatives

Adelia Therapeutics has achieved earn-out milestones outlined in contribution agreement with CybinAdelia ideal acquisition for Cybin, as it leads innovation in researching psychedelic treatment options in the mental health spaceAcquisition results in Cybin obtaining extensive intellectual property portfolio and product pipeline Cybin (NEO: CYBN) (OTC: CLXPF), a life sciences company advancing psychedelic therapeutics for various psychiatric and neurological conditions, has announced that its recently acquired…

Thursday Feb 25, 2021 - 12:28 pm

Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) Inks First CBD Oil Commercial Sale; Looks to Grow in Key Spaces

Pure Extracts is preparing to deliver shipment of 85% pure CBD distillateCompany proud of quality offering produced in world-class facilityPULL uses proprietary state-of-the art, sub-critical/super-critical CO2extraction system Pure Extracts Technologies (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ), a plant-based extraction company, has signed a contract for its first CBD oil commercial sale on the wholesale market (https://ibn.fm/92kPG). Pure Extracts is preparing to deliver the first of what it anticipates…

Thursday Feb 18, 2021 - 10:00 am

Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) Enters Large Cannabis Biomass Agreements to Scale Up Extract Production, Announces DTC Eligibility of Common Shares in the U.S.

Pure Extracts entered into two large biomass purchase agreements, plans to ramp up production of high-potency THC and CBD extracts in 2021Company expects historically low biomass purchase price will produce $590,000 revenueCompany recently announced DTC eligibility of common shares for increased settlement and clearance speeds, wider access to brokerage firms Pure Extracts Technologies (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ), a plant-based extraction company that focuses…

Tuesday Feb 16, 2021 - 2:14 pm

Pure Extracts Technologies (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) Delineates Parameters and Timeline of Study into Psilocybin-Based Active Treatments

Pure Extract Technologies pursues study into psilocybin active treatmentsStudy to extend for 250-day period, targeting a number of milestonesThe study is set to be carried out at Toronto Institute of Pharmaceutical Technology, will be supervised by Pure Extracts’ scientific advisor, Dr. Alexander MacGregorOregon recently voted to legalize psilocybin mushrooms for therapeutic use, a potential legislative movement which may soon be replicated in other jurisdictions Pure…

Wednesday Feb 03, 2021 - 2:55 pm

Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) Updates Investors Following Completion of Special Warrants Private Placement

Pure Extracts recently updated investors on successful completion of second tranche of its special warrants private placementIn aggregate, Company will raise gross proceeds of $8.5 million through both tranches of private placementPure Extracts will employ net proceeds from private placement towards capacity expansion for Company’s extraction business, and for general working capital purposesCompany previously revealed that it was conducting study looking into formulation, manufacturing of…

Tuesday Feb 02, 2021 - 3:32 pm

XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Is ‘One to Watch’

XPhyto Therapeutics Corp. is a bioscience accelerator focused on next-generation drug delivery, diagnostic and new active pharmaceutical ingredient investment opportunitiesThe company has research and development operations in North America and Europe and an operational focus in GermanyXPhyto’s operations are concentrated into three core divisions: infectious disease diagnostics, clinical development of transdermal and sublingual drug formulations, and psychedelic medicineThe company’s lead diagnostic product is an accurate,…

Thursday Jan 28, 2021 - 11:44 am

Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) Increases Private Placement, Begins Trading on OTC Market

Pure Extracts upsizes private placement to total 16,900,000 special warrants at price of $0.505.PULL also received approval from OTC Markets, is trading on OTC Market under ticker symbol PRXTF.Trading under new OTC ticker is “major step forward,” says Company CEO. Pure Extracts Technologies (CSE PULL) (OTC: PRXTF) (XFRA: A2QJAJ), a plant-based extraction company, has increased its non-brokered private placement offering of special warrants; the original…

Wednesday Jan 20, 2021 - 2:14 pm

Cybin Inc. (NEO: CYBN) Announces Partnership with Neurotech Pioneer to Leverage Innovative Technology for Psychedelic Therapeutics

CYBN partners with pioneer company focused on exploring, quantifying the human mindInnovative Flow technology adds exciting dimension to Cybin’s commitment to develop breakthrough treatments for mental health disordersInnovative technology opens new frontier in psychedelic therapeutics Cybin (NEO: CYBN), a life sciences company advancing psychedelic therapeutics for various psychiatric and neurological conditions, is partnering with neurotech pioneer HI, LLC dba Kernel to quantify brain activity in…

Wednesday Jan 20, 2021 - 1:59 pm

Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) Commences Research into Psilocybin-Based Active Treatments

Pure Extracts commences study into psilocybin-based active treatmentsStudy set to be carried out at Toronto Institute of Pharmaceutical Technology, supervised by Pure Extracts’ scientific advisor, Dr. Alexander MacGregorStudy will delve into carrying out conformity testing, stability testing for psilocybin products thereby commencing the R&D that will ultimately take place at Pure Extracts’ purpose-built research space at its facility in British ColumbiaFunctional mushroom, psychedelic drug market…

Tuesday Jan 12, 2021 - 11:02 am

Health Canada Grants Selected Physicians Access to Psilocybin Mushrooms as Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) Dives into Functional Mushroom Market

Health Canada recently granted psilocybin testing access to selected physiciansPsilocybin mushrooms shown to help patients suffering from addiction, mental health issuesPure Extracts’ ’Pure Mushrooms’ and ‘Pure Pulls’ branded products expected to be available by end of Q1 2021 In a recent virtual townhall, Canadian Health Minister Patty Hajdu disclosed that the Canadian government has recently granted access to psilocybin or “psychedelic” mushrooms to several physicians…

Wednesday Jan 06, 2021 - 1:58 pm

Pure Extracts Technologies (CSE: PULL) Draws Out Expansion Plans in Anticipation of Regulatory Changes Within Mushroom Sector

Pure Extracts Technologies Corp. has announced plans to expand, build fourth unit in dedicated towards research, development of psilocybinAnnouncement on its expansion plans come shortly after the Company revealed it plans to apply to Health Canada for a Dealer’s LicenseAward of Dealer’s License would allow Pure Extracts to cultivate, harvest and procure controlled substances and carry out research into psychedelic compounds such as psilocybin and…

Tuesday Jan 05, 2021 - 1:02 pm

Cybin Inc. (NEO: CYBN) R&D Sees Hope in Growing Acceptance of Psilocybin

U.S. taking actionable steps toward acceptance of psilocybinStates, individual cities have decriminalized, made use and possession of psilocybin low law-enforcement priorityMore psilocybin research being done focused on health, well-being of Americans facing a mental health crisis on epic levels Cybin (NEO: CYBN) is a life science company focused on the pharmaceutical development of psychedelic products. The company's subsidiary Serenity Life Sciences is focused on the…

Thursday Dec 31, 2020 - 12:09 pm

Cybin Inc. (NEO: CYBN) Targets Major Depressive Disorder with Breakthrough Therapy

Oregon is first state to permit supervised use of psilocybin, signaling shift in stigmaCYBN entering phase 2 of clinical study of sublingual psilocybin for the potential treatment of MDDNewly discoverable data from psychedelic studies may potentially create entirely new marketplace of safe and effective drugs Cybin (NEO: CYBN), a mushroom life sciences company, is working to become the first to bring a psilocybin drug to…

Wednesday Dec 23, 2020 - 12:54 pm

Pure Extracts Technologies (CSE: PULL) Signs LOI with PURICA(TM) to Further Research into Mushrooms Wellness Products

Pure Extracts Technologies revealed it had recently retained global consultancy to advise on application for Dealer’s License under Health CanadaIf granted, license would allow Company to cultivate, conduct research into, commercialize controlled substancesPure Extracts also announced it recently signed LOI to further cooperation with PURICA(TM)( in field of full-spectrum mushroom-derived wellness products and co-develop CBD, mushroom product combinationsPartnership would ideally situate Company to benefit from…

Monday Dec 21, 2020 - 11:02 am

Pure Extracts Technologies Corp. (CSE: PULL) Names Key Advisor; Targets Development of Mushroom Formulations

Pure Extracts is working with Dr. Alexander MacGregor on development of mushroom products, including some combined with CBD.MacGregor is widely renowned as pharmaceutical science inventor, expert in pharmaceutical technology and novel drug-delivery systems.Pure Extracts is focused on expansion of its cannabis extraction business model to include mushroom formulations. Pure Extracts Technologies (CSE: PULL) has established a key collaborative relationship with an expert in translating pharmaceutical…

Thursday Dec 17, 2020 - 1:48 pm

Pure Extract Technologies (CSE: PULL) Provides Update on Expansion into Functional Mushrooms Sector

Pure Extracts Technologies recently provided update into its expansion into functional mushrooms sectorFunctional mushrooms have enjoyed surge in popularity as of late, are increasingly being used in wide variety of healthcare, pharmaceutical productsFunctional mushrooms sector is expected to grow to annual market value of $34.4 billion by 2024Pure Extracts plans to develop high bio-available products derived from functional mushrooms through use of its proprietary extraction…

Wednesday Dec 16, 2020 - 12:43 pm

Traditional Chinese Medicine Takes Root in Western Culture with Rritual Superfoods Product Line

Rritual Superfoods, Inc., is a budding new superfood developer aiming to improve people’s overall wellness with purposefully designed elixirs pairing acclaimed mushroom varieties with adaptogenic herbsThe company was organized earlier this year and has launched three initial product varieties using the Chaga, Reishi and Lion’s Mane mushrooms in tandem with adaptogenic roots plus herbal spices and natural whole foodsRritual’s products are designed to help users…

Tuesday Dec 15, 2020 - 1:42 pm

Cybin Inc. (NEO: CYBN) on Right Path; Johns Hopkins Study Shows Psilocybin Positive Impact on Major Depression

Study published in “JAMA Psychiatry” reveals significant benefits of psilocybin for patients with major depressionMost participants reported improvements; half experienced remission after only four weeksAs an early entrant in the field, Cybin looks well placed to capitalize on growing traction that psychedelics gain as potential treatment of mental health conditions Only two doses of psilocybin accompanied with psychotherapy may lead to significant reductions in depressive…

Monday Dec 07, 2020 - 2:47 pm

Rritual Superfoods Inc. Fields Powerhouse CPG Lineup to Market Functional Mushrooms

Demand for Functional Mushrooms Experiencing CAGR of Over 10 PercentMarket Projected to Increase from $23 billion in 2020 to $34 billion by 202461% of the Americans Say Healthfulness Significantly Impacts Their Food PurchasesRritual Superfoods Offering Functional Products Based on Chaga, Lion’s Mane and Reishi MushroomsCompany Led by Stellar Consumer Packaged Goods (“CPG”) Executive Cast Functional foods are fast-rising fare for a growing number of Americans.…

Wednesday Dec 02, 2020 - 10:00 am

Pure Extracts Technologies Corp. (CSE: PULL) Issues Corporate Update Detailing Operations, Product Strategy and Market Conditions

Pure Extracts is a plant-based extraction company located in British Columbia, Canada that focuses on cannabis, hemp, functional mushroomsPure Extracts’ “Pure Pulls” and “Pure Mushrooms’” branded products expected to be available by end of Q1 2021Global cannabis extract market size expected to reach USD$28.5 billion by 2027 with CAGR of 16.6%; global functional mushrooms market expected to reach USD$34.3 billion by 2024 with CAGR of…

Monday Nov 30, 2020 - 1:21 pm

Emerging Functional Mushroom Market Ripe with Potential for Rritual Superfoods’ New Product Line

Rritual Superfoods, Inc. is positioning itself to supply the emerging demand for high-potential mushrooms dietary elixirs as wellness products that combat stress, enhance immunity against disease and increase mental clarityMarket analysts predict the overall functional foods industry will reach revenues of $268 billion by 2027, and that the functional mushroom segment will grow at a CAGR of 8.04 percent by 2024 as part of the…

Wednesday Nov 25, 2020 - 12:30 pm

Rritual Superfoods’ Extensive Distribution Network Set to Take Functional Mushrooms Mainstream

Functional Mushrooms Market Set for CAGR of 5.6%Expected to Reach $24.85 billion by 2026Rritual Superfoods Has Launched Three Mushroom-based ProductsProducts Boost Immune System, Brain Power and Relieve StressCompany’s Extensive Distribution Network Set to Accelerate Sales Consumers today shop for food with a number of considerations in mind, including food safety and the health benefits of their selected grocery items. This has resulted in increased demand…

Thursday Nov 19, 2020 - 2:32 pm

Pure Extracts Technologies Corp. (CSE: PULL) Begins Trading, Extraction Tolling Business Ramping Up

Pure Extracts Technologies trading on CSE under symbol PULLCompany runs first oil extraction, distillation under new licensesPULL products highly desired by provincial dispensaries as consumers gravitate to FSO An emerging leader in extraction, Pure Extracts Technologies (CSE: PULL) began trading on the Canadian Securities Exchange (“CSE”) earlier this month under the symbol ‘PULL’. The plant-based extraction Company focuses on cannabis, hemp, and functional mushroom sectors…

Wednesday Nov 18, 2020 - 11:54 am

Pure Extracts Technologies Corp. (CSE: PULL) Now Trading on the Canadian Securities Exchange Under “PULL” Symbol

Pure Extracts trading on CSE under “PULL” symbolPure Extracts cannabis and hemp industry verticals include toll processing, white labeling and developing its own private label of cannabis productsPure Extracts is entering the functional mushroom marketCompany’s CO2 extraction facility complies with European Union GMP standards - intends to seek EU GMP certification for exports to Europe Pure Extracts Technologies (CSE: PULL), a plant-based extraction company focused…

Friday Nov 13, 2020 - 10:49 am

Rritual Superfoods Gains Important USDA Organic Certification for Emerging Industry Superfood Elixirs

Plant-based superfood developer Rritual Superfoods Inc. gained certification from the USDA validating its organic product marketing recently, helping to establish the company’s premium functional food elixirs following their launch in SeptemberThe initial three product line elixirs, shots and mixes promote wellness by blending select nutraceutical mushrooms with adaptogenic roots to promote the body’s immune and cognitive function, as well as to reduce stressMarket analysts predict…

Friday Nov 06, 2020 - 3:04 pm

Rritual Mushrooms Lauded for Attractive Product Marketing and Growth During Annual Awards

Plant-based superfood developer Rritual Mushrooms Inc. has produced its initial product lineup of three functional mushroom elixirs and powders designed to boost personal wellnessThe company was recognized by retail marketing agency ECRM for its attractive product presentation and growing success, as judged by national outlets including CVS, Vitamin Shoppe, Amazon and Rite AidThe functional mushroom market is a nascent subsection of the wellness industry ripe…

Tuesday Nov 03, 2020 - 3:59 pm

Pure Extracts Consolidates Hold on Canada’s Extract Sector; Receives Standard Processing Licence from Health Canada

Pure Extracts Technologies specializes in extraction of key molecules, oils from biomassExtracts are used to manufacture THC & CBD oils, edibles, infused beveragesEdible and infused beverage products have been available in Canada since late 2019, taking up 13% market share within Canada’s specialty drug marketPure Extracts recently awarded standard processing license by Health Canada, which will enable the Company to produce clinical trial samples in…

Tuesday Nov 03, 2020 - 3:50 pm

Rritual Mushrooms, Inc. Is Increasing Awareness of Medicinal Mushrooms and Adaptogenic Herbs

The functional mushroom space has no clear leader, allowing for Rritual to target the role as the only premium brand currently on the marketThe company’s premium suite of products will be available first online through their website and the Amazon shopRritual was the runner up for the Buyer’s Choice Award in the virtual ECRM presentation that connects companies with retail establishments creating business relationshipsThe company…

Monday Nov 02, 2020 - 12:36 pm

CYBIN Corp. Set to Benefit from Growing Research, Interest in Psychedelics

Backed by an anonymous donor, Berkeley launches a center for psychedelic science and public educationBerkley follows examples of other notable universities such as Johns Hopkins in Maryland, Imperial College in London, and Canadian Centre for Psychedelic ScienceAs an innovative company focusing on psilocybin, CYBIN is set to capitalize on growing academic, commercial attention UC Berkeley is joining other prominent academic institutions, including Johns Hopkins University…

Articles

Articles Category: Psychedelics

Get Started with InvestorWire

Press Distribution

Explore Press Distribution Solutions

Discover Add-on Solutions